| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |